CM Life Sciences Inc. (CMLFU) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    CM Life Sciences Inc.

    NASDAQ: CMLFU · Real-Time Price · USD
    13.00
    -0.62 (-4.55%)
    At close: Nov 16, 2020, 6:00 AM

    CM Life Sciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024
    Period Ending Dec 31, 2024
    Revenue
    		 305.45M
    Cost of Revenue
    		 111.05M
    Gross Profit
    		 194.4M
    Operating Income
    		 -23.21M
    Interest Income
    		 n/a
    Pretax Income
    		 -52.63M
    Net Income
    		 -52.29M
    Selling & General & Admin
    		 168.48M
    Research & Development
    		 45.72M
    Other Expenses
    		 n/a
    Operating Expenses
    		 214.2M
    Interest Expense
    		 -3.03M
    Selling & Marketing Expenses
    		 67.37M
    Cost & Expenses
    		 325.26M
    Income Tax Expense
    		 -343K
    Shares Outstanding (Basic)
    		 26.89M
    Shares Outstanding (Diluted)
    		 26.89M
    EPS (Basic)
    		 -1.94
    EPS (Diluted)
    		 -1.94
    EBITDA
    		 -23.21M
    EBIT
    		 n/a
    Depreciation & Amortization
    		 n/a

    Add to Watchlist